Safety evaluation of nivolumab (Nivo) concomitant with cetuximab-radiotherapy for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG 3504.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Robert L. Ferris, Maura L. Gillison, Jonathan Harris, A. Dimitrios Colevas, Loren K. Mell, Christina Kong, Richard Jordan, Kevin Moore, Minh Tam Truong, Claudia Kirsch, David Anthony Clump, James Ohr, Kai He, Dukagjin Blakaj, John F. Deeken, Mitchell Machtay, Walter John Curran, Quynh-Thu Le
Institutions: UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, The University of Texas MD Anderson Cancer Center, RTOG Foundation, Stanford Cancer Institute, Moores Cancer Center, Stanford University, University of California, San Francisco, University of California San Diego, Massachusetts General Hospital, North Shore University Hospital, Sidney Kimmel Comprehensive Cancer Center, Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, Inova Health System, University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Winship Cancer Institute, Stanford Medicine
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891752709